ArticleAnnals of surgical oncology2022

Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma.

Keinosuke Ishido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.